Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calmodulin 1 pseudogene 2 (CALM1P2)
- Target
- CALM1P2
- Molecular classification
- Pseudogene (processed)
01
Overview
Calmodulin 1 pseudogene 2 (CALM1P2/TCAG_1643085) is an intronless, non-functional DNA sequence in the human genome, homologous to the calmodulin 1 gene (CALM1), but contains mutations that abolish the open reading frame and prevent protein expression. It is classified as a processed pseudogene and is not involved in any known cellular or disease process. There is no evidence that this pseudogene is transcribed or translated into a functional product, nor does it play a role in signal transduction, cell cycle regulation, or human disease. CALM1P2 should not be considered a therapeutic target.
- Other names
- Calmodulin 1 pseudogene 2TCAG_1643085CALM1P2
Beyond the preview
Go deeper on Calmodulin 1 pseudogene 2 (CALM1P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calmodulin 1 pseudogene 2 (CALM1P2).